← Back to Search
Pyridoxalated Hemoglobin Polyoxyethylene: A Nitric Oxide Scavenger With Antioxidant Activity For The Treatment Of Nitric Oxide-induced Shock.
C. Privalle, T. Talarico, T. Keng, J. DeAngelo
Published 2000 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Hemoglobins modified for therapeutic use as either hemoglobin-based oxygen carriers or scavengers of nitric oxide are currently being evaluated in clinical trials. One such product, pyridoxalated hemoglobin polyoxyethylene conjugate (PHP), is a human-derived and chemically modified hemoglobin that has yielded promising results in Phase II clinical trials, and is entering a pivotal Phase III clinical trial for the treatment of shock associated with systemic inflammatory response syndrome (SIRS). Shock associated with SIRS is a NO-induced shock. PHP, a new mechanism-based therapy, has been demonstrated in clinical trials to have the expected hemodynamic activity of raising blood pressure and reducing catecholamine use, consistent with its mechanism of action as a NO scavenger. PHP is conjugated with polyoxyethylene, which results in a surface-decorated molecule with enhanced circulation time and stability as well as in attachment of soluble red blood cell enzymes, including catalase and superoxide dismutase. PHP thus contains an antioxidant profile similar to the intact red blood cell and is therefore resistant to both initial oxidative modification by oxidants such as hydrogen peroxide and subsequent ferrylhemoglobin formation. These studies suggest both that the redox activity of modified hemoglobins can be attenuated and that modified hemoglobins containing endogenous antioxidants, such as PHP, may have reduced pro-oxidant potential. These antioxidant properties, in addition to the NO-scavenging properties, may allow the use of PHP in other indications in which excess NO, superoxide, or hydrogen peroxide is involved, including ischemia-reperfusion injury and hemorrhagic shock.
This paper references
The reaction of no with superoxide.
R. E. Huie (1993)
Nitric Oxide Scavengers in Sepsis
S. R. Fischer (1998)
Differential susceptibilities of the prosthetic heme of hemoglobin-based red cell substitutes. Implications in the design of safer agents.
Y. Osawa (1993)
Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia.
A. Brady (1992)
Chemical characterization of pyridoxalated hemoglobin polyoxyethylene conjugate.
T. Talarico (2000)
Oxidation of nitrogen oxides by bound dioxygen in hemoproteins.
M. Doyle (1981)
Alterations in nitric oxide production in various forms of circulatory shock.
C. Szabo (1995)
Reaction of human hemoglobin HbA0 and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate.
R. Cashon (1995)
The nature of reactive species in systems that produce peroxynitrite.
G. Squadrito (1998)
Reaction of peroxynitrite with oxyhaemoglobin: interference with photometrical determination of nitric oxide.
K. Schmidt (1994)
Recombinant human hemoglobin inhibits both constitutive and cytokine-induced nitric oxide-mediated relaxation of rabbit isolated aortic rings.
F. Rioux (1994)
Mechanism of NO-induced oxidation of myoglobin and hemoglobin.
R. Eich (1996)
Effects of pyridoxalated hemoglobin polyoxyethylene conjugate and other hemoglobin-related substances on arterial blood pressure in anesthetized and conscious rats.
Y. Kida (1995)
Nitrosyliron(III) hemoglobin: autoreduction and spectroscopy.
A. Addison (1986)
Initiation of membranal lipid peroxidation by activated metmyoglobin and methemoglobin.
J. Kanner (1985)
Simulation of the diffusion and reaction of endogenously produced nitric oxide.
J. Lancaster (1994)
Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction.
H. Goode (1995)
Consequences of chemical modifications on the free radical reactions of human hemoglobin.
A. Alayash (1992)
Physiological reactions of nitric oxide and hemoglobin: a radical rethink.
S. Gross (1999)
Pathogenetic mechanisms of septic shock.
J. Parrillo (1993)
Diffusion of peroxynitrite across erythrocyte membranes.
A. Denicola (1998)
Peroxynitrite-mediated heme oxidation and protein modification of native and chemically modified hemoglobins.
A. Alayash (1998)
Cooperativity in the dissociation of nitric oxide from hemoglobin.
E. Moore (1976)
The Globin-based Free Radical of Ferryl Hemoglobin Is Detected in Normal Human Blood*
D. Svistunenko (1997)
S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control
L. Jia (1996)
Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is haemoglobin a biological Fenton reagent?
A. Puppo (1988)
Acellular and cellular hemoglobin solutions as vasoconstrictive factor.
K. Nakai (1994)
Xanthine oxidase activity and free radical generation in patients with sepsis syndrome.
H. Galley (1996)
Formation of free radicals and nitric oxide derivative of hemoglobin in rats during shock syndrome.
U. Westenberger (1990)
Release of iron from hemoglobin.
S. Panter (1994)
Conformation, co-operativity and ligand binding in human hemoglobin.
R. Cassoly (1975)
Effects of intra- and intermolecular crosslinking on the free radical reactions of bovine hemoglobins.
A. Alayash (1995)
The Biology of Nitric Oxide, Part 7
B. Brüne (2001)
Hemoglobin-based oxygen carriers: development and clinical potential.
E. M. Ketcham (1999)
Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.
J. Parrillo (1990)
Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution.
R. Przybelski (1996)
Effects of Hemoglobin in Sepsis
S. R. Fischer (1997)
Reactions between nitric oxide and haemoglobin under physiological conditions
A. Gow (1998)
Large scale production and characterization of lyophilized pyridoxalated hemoglobin-polyoxyethylene (PHP).
S. Matsumura (1992)
Nitric oxide and shock.
R. Kilbourn (1997)
CONTINUOUS INFUSION OF PYRIDOXALATED HEMOGLOBIN POLYOXYETHYLENE CONJUGATE IN HYPERDYNAMIC SEPTIC SHEEP
H. Bone (1998)
L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells.
J. Hibbs (1987)
Future prospects for artificial blood.
T. Chang (1999)
Kinetic and spectroscopic characterization of an intermediate peroxynitrite complex in the nitrogen monoxide induced oxidation of oxyhemoglobin 1
S. Herold (1999)
Nitric oxide scavengers in the treatment of shock associated with systemic inflammatory response syndrome
J. Angelo (1999)
Nitric oxide hemoglobin in mice and rats in endotoxic shock.
Q. Wang (1991)
Colloid osmotic properties of modified hemoglobins: chemically cross-linked versus polyethylene glycol surface-conjugated.
K. Vandegriff (1997)
Comparison of the haemodynamic effects of nitric oxide synthase inhibition and nitric oxide scavenging in endotoxaemic sheep
H. Bone (1998)
Nitric Oxide Binding to Human Ferrihemoglobins Cross-Linked between Either α or β Subunits
A. Alayash (1993)
Tissue injury caused by deposition of immune complexes is L-arginine dependent.
M. Mulligan (1991)
A novel antioxidant role for hemoglobin. The comproportionation of ferrylhemoglobin with oxyhemoglobin.
C. Giulivi (1990)
Mechanistic studies of the oxidation of pyridoxalated hemoglobin polyoxyethylene conjugate by nitrogen monoxide.
S. Herold (1999)
Redox reactivity of modified hemoglobins with hydrogen peroxide and nitric oxide: toxicological implications.
A. Alayash (1994)
L-arginine: nitric oxide pathway in endotoxemia and human septic shock.
J. Gómez-jiménez (1995)
Oxalated pyridoxalated hemoglobin polyoxyethylene conjugate normalizes the hyperdynamic circulation in septic sheep.
H. G. Bone (1997)
Three-point cross-linking: potential red cell substitutes from the reaction of trimesoyl tris(methyl phosphate) with hemoglobin.
R. Kluger (1992)
[Preoperative hemodilution with bovine hemoglobin. Acute hemodynamic effects in liver surgery patients ].
T. Standl (1997)
Yearbook of Intensive Care and Emergency Medicine
J. Vincent (1995)
Pyridoxalated hemoglobin polyoxyethylene conjugate does not restore hypoxic pulmonary vasoconstriction in ovine sepsis.
S. R. Fischer (1997)
Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin.
Y. Miller (1997)
Reduction of hydroxyl radical generation in a rat hindlimb model of ischemia-reperfusion injury using crosslinked hemoglobin-superoxide dismutase-catalase.
F. D'Agnillo (1997)
Acellular hemoglobin-mediated oxidative stress toward endothelium: a role for ferryl iron.
D. W. Goldman (1998)
Conjugated Human Hemoglobin as a Physiological Oxygen Carrier - Pyridoxalated Hemoglobin Polyoxyethylene Conjugate (PHP)
P. Malchesky (1990)
Pyridoxalated hemoglobin polyoxyethylene (PHP) - a modified hemoglobin therapeutic with SOD-catalase activity
C. T. Privalle (1999)
Nitrogen oxide levels in patients after trauma and during sepsis.
J. Ochoa (1991)
Crosslinked hemoglobin-superoxide dismutase-catalase scavenges free radicals in a rat model of intestinal ischemia-reperfusion injury.
S. Razack (1997)
Spectrin‐haemoglobin crosslinkages associated with in vitro oxidant hypersensitivity in pathologic and artificially dehydrated red cells
N. Sauberman (1983)
The biology of nitric oxide, part 5
W. A. Pryor (1996)
Novel roles of nitric oxide in hemorrhagic shock.
C. Szabo (1999)
Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis.
R. Kilbourn (1990)
Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock.
N. Fukuyama (1997)
Blood Substitute Oxygen Carriers Designed for Clinical Applications
R. Winslow (1996)
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.
R. Bone (1992)
Clinical Effects of Cell-Free Hemoglobin, a Scavenger of Nitric Oxide, in Septic Shock
R. Kilbourn (1997)
The oxyhemoglobin reaction of nitric oxide.
A. Gow (1999)
Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils.
A. L. Van Dervort (1994)
Absence of hemoprotein-associated free radical events following oxidant challenge of crosslinked hemoglobin-superoxide dismutase catalase.
F. D'Agnillo (1998)
Pyridoxalated hemoglobin polyoxyethylene conjugate reverses hyperdynamic circulation in septic sheep.
H. Bone (1998)
Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties
F. D'agnillo (1998)
Chapter III.8 – Hemoglobin-Based Blood Substitutes
A. Rudolph (1998)
An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shock
R. Grover (1999)
A new resuscitation fluid "stabilized hemoglobin" preparation and characteristics.
Y. Iwashita (1988)
Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1----lysine 99 alpha 2).
R. Chatterjee (1986)
The dissociation of NO from nitrosylhemoglobin.
V. Sharma (1978)
Nitrogen monoxide-related disease and nitrogen monoxide scavengers as potential drugs.
F. Sp (1999)
Autoxidation of pyridoxalated hemoglobin polyoxyethylene conjugate.
T. Talarico (1998)
Präoperative Hämodilution mit bovinem Hämoglobin Akute hämodynamische Auswirkungen bei Patienten in der Leberchirurgie
T. Standl (1997)
Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient.
J. Stamler (1997)
Reaction of nitric oxide with heme proteins and model compounds of hemoglobin.
V. Sharma (1987)
The toxicities of native and modified hemoglobins.
J. Everse (1997)
Detection of nitric oxide production in lipopolysaccharide-treated rats by ESR using carbon monoxide hemoglobin.
H. Kosaka (1992)
Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?
A. Alayash (1999)
This paper is referenced by
Hb‐based oxygen carriers: are we there yet?
T. Reid (2003)
A Review of Polymorphisms in the Human Gene for Inducible Nitric Oxide Synthase (NOS2) in Patients with Malaria
M. Levesque (2001)
Peroxynitrite-scavenging constituents from the brown algaSargassum thunbergii
Y. Seo (2004)
Synthesis, antioxidant and antimicrobial activity of novel benzene‐1,4‐diamine‐bis‐dioxaphosphepine‐6λ5 iminophosphoranes
M. V. N. Reddy (2010)
Electrochemical investigation of immobilized hemoglobin: redox chemistry and enzymatic catalysis.
Huihong Liu (2006)
Hemoglobin-based Oxygen Carriers: Current Status and Future Directions
Toby A Silverman (2009)
Oxygen Delivery by Allosteric Effectors of Hemoglobin, Blood Substitutes, and Plasma Expanders
B. Campanini (2003)
Subtilisin QK, a fibrinolytic enzyme, inhibits the exogenous nitrite and hydrogen peroxide induced protein nitration, in vitro and in vivo.
Juho Ko (2005)
Chapter 19 – Pro-Oxidant Activity of Hemoglobin and Endothelial Cytotoxicity
Felice D'Agnillo (2006)
O‐raffinose crosslinked hemoglobin lacks site‐specific chemistry in the central cavity: Structural and functional consequences of β93Cys modification
R. Boykins (2005)
Influence of different oxygen modes on the blood oxygen transport and prooxidant-antioxidant status during hepatic ischemia/reperfusion.
Zinchuk Vv (2003)
Polymer/hemoglobin assemblies: biodegradable oxygen carriers for artificial red blood cells.
Taihang Li (2011)
Polymerized bovine hemoglobin decreases oxygen delivery during normoxia and acute hypoxia in the rat.
D. Irwin (2008)
Pyridoxalated haemoglobin polyoxyethylene conjugate, a nitric oxide scavenger, decreases dose-limiting hypotension associated with interleukin-2 (IL-2) therapy.
K. Murakami (2003)
Hemoglobin-Based Blood Substitutes – Preparation Technologies and Challenges
X. Lu (2011)
Oxygen Delivery via Allosteric Effectors of Hemoglobin and Blood Substitutes
S. Bruno (2010)
Qualitative Determination of Hemoglobin in Rats with Septic Shock by Photoacoustic Spectroscopy
Sindy Janneth Olvera Vázquez (2019)
The activity of recombinant human neuroglobin as an antioxidant and free radical scavenger
W. Li (2011)
Changing epidemiology of invasive candidiasis in intensive care units--much ado about nothing?
J. Sobel (2008)
New therapies and vaccines for meningococcal disease
E. Carrol (2001)
Blood Cell Substitutes
T. Chang (2002)
What sense lies in antisense inhibition of inducible nitric oxide synthase expression?
K. Hemmrich (2005)
INTERPRETATION OF HEMOLYSIS TESTS FOLLOWING ADMINISTRATION OF A SECOND-GENERATION HEMOGLOBIN-BASED OXYGEN CARRIER
S. Drieghe (2013)
Anti-inflammatory strategies for the treatment of sepsis
N. Riedemann (2003)
Antisense Inhibition of Inducible Nitric Oxide Synthase Expression - Does it make Sense?
K. Hemmrich (2005)
Setbacks in blood substitutes research and development: a biochemical perspective.
A. Alayash (2010)
Les transporteurs d'oxygène ou substituts sanguins
M. Audran (2002)
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity
V. Calabrese (2007)
Sadly, pyridoxalated hemoglobin polyoxyethylene is more a dodo than a PHOENIX.
J. Ball (2015)
Polynitroxyl hemoglobin: a pharmacokinetic study of covalently bound nitroxides to hemoglobin platforms.
P. Buehler (2004)
Protection of insulin secreting cells from nitric oxide induced cellular damage by crosslinked hemoglobin.
S. Chae (2004)
Artificial Oxygen Carriers – a Critical Analysis
S. Dinkelmann (2002)See more